Small Cell Lung Carcinoma
📧 Sign up to get email alerts when something new happens for Small Cell Lung Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial update reports completion of a study evaluating an immunotherapy in combination with chemoradiation for advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer [Phase 3]
Phase 3 trial of RRx-001 with platinum doublet in small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer [Phase 2]
Phase 2 trial evaluating biomarkers for nivolumab and ipilimumab and their combination in lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Study of AK-01 (LY3295668) in Solid Tumors [Phase 1, Phase 2]
A two-phase clinical trial evaluating AK-01 (LY3295668) in solid tumors has completed phases 1 and 2 with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC） [Phase 2]
Phase 2 trial evaluating sequential camrelizumab with chemotherapy (irinotecan + platinum) followed by apatinib in untreated advanced small …
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma [Phase 1]
Phase 1 trial update for GSK2879552 in relapsed/refractory small cell lung carcinoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 trial of talazoparib in advanced or recurrent solid tumors shows safety data and preliminary activity; results posted.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide [Phase 1, Phase 2]
Phase I/II study evaluating the maximum tolerated dose and safety of CC-4047 (pomalidomide) with cisplatin and etoposide in small cell carci…